LUMEVOQ® (GS010; lenadogene nolparvovec) is a rare maternally inherited mitochondrial genetic disease, characterized by the degeneration of retinal ganglion cells that results in brutal and irreversible vision loss. The results were presented at the 2024 annual meeting of the North American Neuro-Ophthalmology Society (NANOS)